Summary & Overview
CPT 5060F: Performance Measure Entry, No Summary Available
CPT code 5060F is a CPT-formatted code entry for which no descriptive summary was provided in the source input. As a CPT code, 5060F is recorded within the Current Procedural Terminology system and is relevant for clinical documentation and billing workflows where precise coding is required. Nationally, accurate labeling of such CPT entries supports claims processing, quality measurement, and interoperability across payers and health systems.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what this code represents, the available context on service type and site of service when present, and identification of missing data elements. The publication outlines what benchmarks and policy or clinical context would be relevant if full metadata were available and directs readers to the specific fields that require supplemental source documentation for complete utilization guidance.
This summary is intended for billing managers, compliance officers, and policy analysts who need a concise national-level description of the code's role in claims and documentation, and to highlight which data elements are present and which are not available in the provided input.
Billing Code Overview
CPT code 5060F has no summary available in the source description. Based on the code listing, this entry represents a performance or clinical measure item recorded using a CPT-format code. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a middle-aged adult presenting to a urology clinic with symptoms of recurrent urinary tract infections, flank pain, hematuria, or obstructive uropathy suspected to be due to ureteral stenosis or stricture. The clinician plans an outpatient endoscopic evaluation and possible intervention of the ureter. The workflow includes pre-procedure evaluation (history, focused genitourinary exam, urinalysis, urine culture), informed consent, peri-procedural antibiotics if indicated, and scheduling in an ambulatory surgery center or hospital outpatient department. During the procedure, cystoscopy with retrograde pyelography is performed to visualize the ureter; diagnostic ureteroscopy may be done to directly inspect and treat ureteral lesions, strictures, or remove small calculi. A ureteral stent placement or dilation may follow if needed. Post-procedure instructions include activity restrictions, analgesia, and follow-up for stent removal or imaging to confirm resolution of obstruction. Typical sites of service are the ambulatory surgery center (ASC) or hospital outpatient department; some diagnostic cystoscopic evaluations may occur in the physician office if appropriate equipment and sedation capability are available.
Coding Specifications
- Data not available in the input.
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |